» Articles » PMID: 2200605

Serology of Coccidioidomycosis

Overview
Specialty Microbiology
Date 1990 Jul 1
PMID 2200605
Citations 103
Authors
Affiliations
Soon will be listed here.
Abstract

Serologic tests have assisted in the diagnosis and prognosis of coccidioidomycosis for a half-century. The causative agent, Coccidioides immitis, is a dimorphic fungus existing in a hyphal form with arthroconidia in nature and in the usual culture. The arthroconidia represent the inhaled infective forms which in vivo and under special laboratory conditions form spherules which endosporulate. The culture filtrate/autolysate (coccidioidin) from the hyphal phase has provided antigens of suitable reliability for currently used serologic tests. These tests are primarily to determine the two major antibody responses: the early immunoglobulin M (IgM) response is useful in the diagnosis of acute primary coccidioidomycosis. Later, IgG is produced and usually outlasts the IgM, persisting in chronic coccidioidomycosis. The IgM is detectable by tube precipitin, a corresponding immunodiffusion, or latex particle agglutination tests. The pertinent antigen(s) is heat stable and pronase resistant and appears to be largely carbohydrate, mainly mannose with some 3-O-methyl mannose. The IgG detectable in the serum and other body fluids by complement fixation and a corresponding immuno-diffusion is useful in diagnosis, and its quantitation provides an indicator of progression of disease (increasing titer) or regression (decreasing titer). The pertinent antigen appears to be a heat-labile, pronase-sensitive protein which in an unreduced form has a molecular weight of 110,000. A third very useful serologic procedure is the exoantigen test for identification of putative cultures of C. immitis.

Citing Articles

Cavitary Pneumonia Causes in the Arid Landscapes of Southern Arizona.

El Kurdi R, Nayar K, Gotway M, Blair J, Nagarakanti S Am J Med Open. 2025; 13:100090.

PMID: 40061083 PMC: 11889622. DOI: 10.1016/j.ajmo.2025.100090.


Overview of the Current Challenges in Pulmonary Coccidioidomycosis.

Fayed M, Evans T, Almasri E, Bilello K, Libke R, Peterson M J Fungi (Basel). 2024; 10(10).

PMID: 39452676 PMC: 11508864. DOI: 10.3390/jof10100724.


Improving Coccidioidomycosis Testing for Emergency Department Patients With Suspect Community-Acquired Pneumonia: Analysis of Provider Attitudes and the Effect of a Targeted Intervention.

Cunningham C, Brown A, Ravi S, Bearss J, OShea M, Elshaer A Open Forum Infect Dis. 2024; 11(8):ofae461.

PMID: 39192992 PMC: 11347941. DOI: 10.1093/ofid/ofae461.


Discovery of a Unique Set of Dog-Seroreactive Proteins Using Nucleic Acid Programmable Protein Array.

Koehler M, Song L, Grill F, Shubitz L, Powell D, Galgiani J J Fungi (Basel). 2024; 10(5).

PMID: 38786662 PMC: 11121964. DOI: 10.3390/jof10050307.


A Clinicopathological Categorization System for Clinical Research in Coccidioidomycosis.

Krogstad P, Thompson 3rd G, Heidari A, Kuran R, Stephens A, Butte M Open Forum Infect Dis. 2023; 10(12):ofad597.

PMID: 38156047 PMC: 10753911. DOI: 10.1093/ofid/ofad597.


References
1.
Jensen T, Schonheyder H, Andersen P, STENDERUP A . Binding of C-reactive protein to Aspergillus fumigatus fractions. J Med Microbiol. 1986; 21(2):173-7. DOI: 10.1099/00222615-21-2-173. View

2.
LEVINE H, COBB J, Smith C . Immunity to coccidioi-domycosis induced in mice by purified spherule, arthrospore, and mycelial vaccines. Trans N Y Acad Sci. 1960; 22:436-49. DOI: 10.1111/j.2164-0947.1960.tb00711.x. View

3.
Sawaki Y, Huppert M, Bailey J, Yagi Y . Patterns of human antibody reactions in coccidioidomycosis. J Bacteriol. 1966; 91(1):422-7. PMC: 315963. DOI: 10.1128/jb.91.1.422-427.1966. View

4.
Weiner M . Antigenemia detected in human coccidioidomycosis. J Clin Microbiol. 1983; 18(1):136-42. PMC: 270756. DOI: 10.1128/jcm.18.1.136-142.1983. View

5.
NIMMICH W . Occurrence of 3-O-methylmannose in lipopolysaccharides of Klebsiella and Escherichia coli. Biochim Biophys Acta. 1970; 215(1):189-91. DOI: 10.1016/0304-4165(70)90403-4. View